Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

New therapies for rare skin diseases show promise but need more research.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Dupilumab for eczema may cause hair loss.

Hair loss requires customized treatments based on its various causes and types.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

Arctium lappa L. might help treat immune-related skin diseases, but more research is needed.

Children with celiac disease often have skin issues, best managed with a gluten-free diet and sometimes medication.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.